Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The debt to assets ratio is 0.00% as of the fiscal period ended Friday, July 31, 2026.
Reported quarterly debt to assets ratio; no daily interpolation. Q1 FY2027 (2026-07-31): 0.00%.
DEBT TO ASSETS RATIO
0.00%
DEBT TO ASSETS RATIO AVG TTM
0.00%
DEBT TO ASSETS RATIO AVG 3Y
0.00%
DEBT TO ASSETS RATIO AVG 5Y
0.00%
DEBT TO ASSETS RATIO AVG 10Y
1.86%
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
-100.00%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 536 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Alzamend Neuro Inc
Market Cap
$5.48M
Debt to Assets Ratio
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$5.47M
Debt to Assets Ratio
0.15%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.59M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.24M
Debt to Assets Ratio
0.49%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.21M
Debt to Assets Ratio
0.42%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.95M
Debt to Assets Ratio
0.06%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alzamend Neuro Inc (ALZN) | $5.48M | 0.00% | 0.00% | 0.00% | 0.00% |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.47M | 0.15% | N/A | N/A | N/A |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.59M | 0.00% | N/A | N/A | N/A |
| Lunai Bioworks Inc. (LNAI)vs › | $5.35M | 0.14% | N/A | N/A | N/A |
| Imunon, Inc. (IMNN)vs › | $5.29M | 0.52% | N/A | N/A | N/A |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.24M | 0.49% | N/A | N/A | N/A |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $5.21M | 0.42% | N/A | N/A | N/A |
| Lucyd, Inc (LUCY)vs › | $5.81M | 0.01% | N/A | N/A | N/A |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $5.95M | 0.06% | N/A | N/A | N/A |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $6.04M | 0.05% | N/A | N/A | N/A |
Debt/Assets
0.0%
Debt/Equity
0.00
Current Ratio
3.01
Interest Coverage
1324.5x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-07-31 | 0.00% |
| 2026-04-30 | 0.00% |
| 2026-01-31 | 0.00% |
| 2025-10-31 | 0.00% |
| 2025-07-31 | 0.00% |
| 2025-04-30 | 0.00% |
| 2025-01-31 | 0.00% |
| 2024-10-31 | 0.00% |
| 2024-07-31 | 0.00% |
| 2024-04-30 | 47.61% |
| 2024-01-31 | 56.03% |
| 2023-10-31 | 0.00% |
| 2023-07-31 | 0.00% |
| 2023-04-30 | 0.00% |
| 2023-01-31 | 0.00% |
| 2022-10-31 | 0.00% |
| 2022-07-31 | 0.00% |
| 2022-04-30 | 0.00% |
| 2022-01-31 | 0.00% |
| 2021-10-31 | 2.38% |
| 2021-07-31 | 2.02% |
| 2021-04-30 | 11.51% |
| 2021-01-31 | 152.23% |
| 2020-04-30 | 3.45% |
| 2019-10-31 | 2.90% |
| 2019-07-31 | 2.90% |
| 2019-04-30 | 5.29% |
| 2019-01-31 | 5.29% |
| 2018-10-31 | 3.36% |
| 2018-07-31 | 3.36% |
| 2018-04-30 | 0.00% |
| 2018-01-31 | 0.00% |
| 2017-10-31 | 64.63% |
| 2017-07-31 | 64.63% |
| 2017-04-30 | 446.93% |
| 2017-01-31 | 446.93% |
| 2016-10-31 | 7.56% |
| 2016-07-31 | 7.56% |
